Supporting runners every step of the way
WashU Medicine serves as the official medical provider — and more — at the Greater St. Louis Marathon.
$12 million NIH grant supports study of Alzheimer’s risk factors
Researchers at WashU Medicine will investigate genetic and molecular factors behind the disease’s disproportionate prevalence in Caribbean populations, with the aim of identifying new drug targets.
Teaching Public Health
Volume Two
In an era shaped by the seismic effects of the COVID-19 pandemic and politically derived challenges, the second volume of “Teaching Public Health” offers a timely and essential contribution to the evolving field of public health education.
Grants bolster research on myelodysplastic syndromes
Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.
mRNA vaccines follow unconventional immune path to destroy tumors
WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.
Environmental enrichment reduces fentanyl relapse in rats
A study by WashU Medicine researchers offers new insight into
how environmental factors protect against opioid addiction and support recovery.
Simple procedure relieves painful complications after deep vein thrombosis
A clinical trial co-led by WashU Medicine researchers has shown that a painful complication of blood clots can be treated by inserting a stent into the affected vein.
New research sheds light on the path of neurodegenerative diseases
Researchers from the WashU McKelvey School of Engineering are reshaping our understanding of disease origins and revealing how biomolecular condensates can tip cells from normal behavior to dysfunction.
Myth vs. reality: Most Missouri Medicaid recipients already are working, WashU analysis shows
New data challenge assumptions, showing Missouri Medicaid recipients are largely employed — often in jobs without benefits, reflecting gaps in wages, coverage and rural access.
WashU launches doctoral program in neuroengineering
WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.
Older Stories